Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02277665 · ClinicalTrials.gov registry record · NA
Clinical Trial Tobacco Marijuana
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT02277665 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 67 participants.
The verdict
NCT02277665, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
Approximately 50% of persons seeking treatment for cannabis-use disorders (CUDs) regularly smoke tobacco. Combining tobacco with cannabis has become a common method of smoking cannabis. Similarities of use, and using together, can make quitting difficult. Stopping tobacco simultaneously with cannabis may be beneficial. Little scientific information currently addresses how to best target tobacco smoking during treatment for CUDs. Our long-term goal is to develop an effective protocol for intervening in tobacco smoking without changing cannabis outcomes. This protocol reflects the planned Stage 1, proof-of-concept study that will compare a combined cannabis and tobacco intervention to one that targets CUD only. Hypotheses assert that the intervention (1) will be accepted by the majority of eligible participants (2) will result in more tobacco quit attempts and rates than the CUD-only treatment; and (3) will not adversely affect cannabis outcomes. Last, the project will evaluate the potential of specific moderators of outcomes to predict outcomes and inform subsequent treatment development efforts. If the hypotheses were confirmed, dissemination of this protocol would reduce adverse psychosocial and health consequences of tobacco or cannabis dependence. Findings will inform future development of prevention and intervention strategies.
Interventions
- BEHAVIORAL CUD Treatment
- BEHAVIORAL Tobacco Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2014-12-18 |
| Est. Completion | 2017-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02277665
The ClinicalTrials.gov registry entry for NCT02277665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CUD Treatment is the first listed.
NCT02277665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02277665 about?
NCT02277665 is a clinical study titled "Clinical Trial Tobacco Marijuana". Approximately 50% of persons seeking treatment for cannabis-use disorders (CUDs) regularly smoke tobacco. Combining tobacco with cannabis has become a common method of smoking cannabis. Similarities of use, and using together, can make quitting difficult. Stopping tobacco simultaneously with cannabi...
What is the current status of trial NCT02277665?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2014-12-18. Estimated completion is 2017-01-18.
What interventions are being tested in trial NCT02277665?
The interventions under investigation include: CUD Treatment (BEHAVIORAL), Tobacco Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02277665?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.